Non ST-elevation myocardial infarction: New Zealand management guidelines

N Z Med J. 2005 Oct 7;118(1223):U1680.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Analgesia / standards
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Biomarkers / blood
  • Calcium Channel Blockers / therapeutic use
  • Cardiology / standards*
  • Coronary Angiography / standards
  • Electrocardiography
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Inflammation / metabolism
  • Myocardial Infarction / diagnosis*
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / therapy*
  • Myocardial Revascularization / standards
  • Natriuretic Peptides / metabolism
  • New Zealand
  • Platelet Aggregation Inhibitors / therapeutic use
  • Risk Assessment / methods
  • Troponin / blood

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Biomarkers
  • Calcium Channel Blockers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Natriuretic Peptides
  • Platelet Aggregation Inhibitors
  • Troponin